Thomas A Neff
Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:90.
Jun 16, 2024Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial.
Jun 16, 2024Ann Intensive Care 2024; 14:90
Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin
Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Beck-Schimmer B, Schadde E, Pietsch U, Filipovic M, Dübendorfer-Dalbert S, Fodor P, Hübner T, Schuepbach R, Steiger P, David S, Krüger B, Neff T, Schläpfer M. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial. Ann Intensive Care 2024; 14:41.
Mar 27, 2024Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
Mar 27, 2024Ann Intensive Care 2024; 14:41
Beck-Schimmer Beatrice, Schadde Erik, Pietsch Urs, Filipovic Miodrag, Dübendorfer-Dalbert Seraina, Fodor Patricia, Hübner Tobias, Schuepbach Reto Andreas, Steiger Peter, David Sascha, Krüger Bernard D, Neff Thomas A, Schläpfer Martin
Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial.
Neff T, Braun J, Rana D, Puhan M, Filipovic M, Seeberger M, Stuber F, Neff S, Beck-Schimmer B, Schläpfer M. Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial. Anesth Analg 2022; 134:123-132.
Jan 1, 2022Interleukin-6 Is an Early Plasma Marker of Severe Postoperative Complications in Thoracic Surgery: Exploratory Results From a Substudy of a Randomized Controlled Multicenter Trial.
Jan 1, 2022Anesth Analg 2022; 134:123-132
Neff Thomas A, Braun Julia, Rana Dhanu, Puhan Milo, Filipovic Miodrag, Seeberger Manfred, Stuber Frank, Neff Simona B, Beck-Schimmer Beatrice, Schläpfer Martin
Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial
Beck-Schimmer B, Filipovic M, Schneiter D, Weder W, Vogt A, Stuber F, Risch T, Neff T, Seeberger M, Braun J, Bonvini J, Puhan M. Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial. Anesthesiology 2016; 125:313-21.
Aug 1, 2016Which Anesthesia Regimen Is Best to Reduce Morbidity and Mortality in Lung Surgery?: A Multicenter Randomized Controlled Trial
Aug 1, 2016Anesthesiology 2016; 125:313-21
Beck-Schimmer Beatrice, Filipovic Miodrag, Schneiter Didier, Weder Walter, Vogt Andreas, Stuber Frank, Risch Tobias J, Neff Thomas A, Seeberger Manfred, Braun Julia, Bonvini John M, Puhan Milo